v3.26.1
Segment Information (Tables)
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule Of Segment Reporting

The following table summarizes the reportable segment’s financial information:

 

 

Three Months Ended June 30,

 

 

 

Six Months Ended June 30,

 

 

 

2026

 

 

2025

 

 

 

2026

 

 

2025

 

Collaboration revenue

 

$

7,659

 

 

$

14,245

 

 

 

$

22,707

 

 

$

30,872

 

Less:

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development:

 

 

 

 

 

 

 

 

 

 

 

 

 

   External development expenses - nex-z

 

 

18,268

 

 

 

23,958

 

 

 

 

38,512

 

 

 

47,088

 

   External development expenses - lonvo-z

 

 

9,569

 

 

 

12,053

 

 

 

 

17,711

 

 

 

22,721

 

   Other research and development (1)

 

 

54,758

 

 

 

61,024

 

 

 

 

107,109

 

 

 

135,653

 

       Total research and development

 

 

82,595

 

 

 

97,035

 

 

 

 

163,332

 

 

 

205,462

 

General and administrative (2)

 

 

37,824

 

 

 

27,206

 

 

 

 

72,667

 

 

 

56,213

 

Interest income

 

 

(5,797

)

 

 

(7,402

)

 

 

 

(11,002

)

 

 

(16,005

)

Other segment information (3)

 

 

(329

)

 

 

(1,339

)

 

 

 

575

 

 

 

786

 

Segment and consolidated net loss

 

$

(106,634

)

 

$

(101,255

)

 

 

$

(202,865

)

 

$

(215,584

)
(1)
Includes unallocated research and development expenses, including stock-based compensation of $9.4 million and $17.0 million for the three and six months ended June 30, 2026, respectively, and $14.1 million and $26.7 million for the three and six months ended June 30, 2025, respectively, as disclosed within Note 10, “Stock-Based Compensation.”
(2)
Includes stock-based compensation of $8.6 million and $14.5 million for the three and six months ended June 30, 2026, respectively, and $8.0 million and $17.2 million for the three and six months ended June 30, 2025, respectively, as disclosed within Note 10, “Stock-Based Compensation.”
(3)
Includes change in fair value of investments as disclosed in the Company’s condensed consolidated statements of operations and comprehensive loss.